Scholars Central

Conference abstractPublished 7 May 2018

Antibody-proteases as a novel biomarker and a unique target to suit translational tools to be applied for biodesign and bioengineering

Authors: Sergey Suchkov, Noel Rose, Aleks Gabibov, Harry Schroeder

I. M. Sechenov First Moscow State Medical University, Russia A I Evdokimov Moscow State Medical and Dental University, Russia European Association for Prediction, Prevention and Personalized Medicine, Europe Johns Hopkins Medical Institutions, USA Russian Academy of Sciences, Russia University of Alabama, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Catalytic Abs (catAbs) is multivalent immu-noglobulin (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represents Abs to provide proteolytic effects. Abs against myelin basic protein/ MBP with pro-teolytic activity exhibiting sequence-specific cleavage of MBP is of great value to monitor demyelination whilst in MS. The activity of Ab-proteases was first registered at the sub-clinical stages, 1âÂ?Â?2 years prior to the clinical illness. The activity of the Ab-proteases re-vealed significant correlation with scales of demyelination and the disability of the pa-tients as well. So, the activity of Ab-proteases and its dynamics tested would con-firm a high subclinical and predictive (translational) value of the tools as applicable for personalized monitoring protocols. Of tre-mendous value are Ab-proteases directly af-fecting remodeling of tissues with multilevel architectonics, for instance, myelin. By changing sequence specificity, one may reach reduction of a density of the negative proteo-lytic effects within the myelin sheath and thus minimizing scales of demyelination. Ab-proteases can be programmed and re-programmed to suit the needs of the body metabolism or could be designed for the de-velopment of new catalysts with no natural counterparts. Further studies are needed to secure artificial or edited Ab-proteases as translational tools of the newest generation to diagnose, to monitor, to control and to treat and rehabilitate MS patients at clinical stages and to prevent the disorder at subclinical stages in persons-at-risks. Recent Publications 1. Gabibov A A, Paltsev M A and Suchkov S V (2011) Antibody-associated proteolysis in surveillance of autoimmune demyelination: clinical and preclinical issues. Future Neu-rology 6(3):303âÂ?Â?305. 2. D Kostyushev, I Tsarev, D Gnatenko, M Paltsev and S Suchkov (2011) Myelin-associated serological targets as applicable to diagnostic tools to be used at the preclinical and transient stages of multiple sclerosis pro-gression. Open J Immunology 1(3):80âÂ?Â?86. 3. Gabibov A G, Ponomarenko N A, Tretyak E B, Paltsev M A and Suchkov S V (2006) Catalytic autoantibodies in clinical autoim-munity and modern medicine. Autoimmunity Reviews 5:324âÂ?Â?330. 4. Ponomarenko N A, Durova O M, Vorobiev I I, Belogurov A A, Telegin G B, et al. (2005) Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale. Immunol. Lett. 103(1):45âÂ?Â?50. 5. Mysikov V K, Pronina O A, Gnuchev N V, Stepanenko R N, Durova O M, et al. (2002) Humoral immunity in patients with multiple sclerosis. European Journal of Neurology 9(2):2103âÂ?Â?136.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sergey Suchkov”
  • BylineArticles whose byline prints “Noel Rose”
  • BylineArticles whose byline prints “Aleks Gabibov”
  • BylineArticles whose byline prints “Harry Schroeder”